NSE:MEDPLUS News | QuoteStream

quartr

MEDPLUS: Strong revenue growth and network expansion, but margins pressured by mix and cost shifts

Q1 FY27 saw strong revenue growth, with 146 net new stores and diagnostics revenue up YoY. Gross margins declined due to lower private label mix and higher franchisee contribution, but management expects recovery in coming quarters. CapEx for non-core projects is on hold following investor feedback…

Quartr en 7/22/2026, 09:30 PM GMT+8

StocksIN

MEDPLUS

quartr

MEDPLUS: Revenue up 21.8% YoY, but margins declined; diagnostics and store expansion strong

Revenue grew 21.8% YoY to 18,796 million, but gross margin and operating EBITDA margin declined due to lower private label sales and higher expenses. Diagnostics segment delivered strong revenue and EBITDA growth, while 146 new stores were added and capex remained below plan.Original document: MedP…

Quartr en 7/21/2026, 10:17 PM GMT+8

StocksIN

MEDPLUS

reuters

Medplus Health Services Says Optival Health Solutions Receives Suspension Order For Drug License Of Store In Karnataka

MedPlus Health Services Ltd NSE:MEDPLUS:

Reuters en 7/1/2026, 08:27 PM GMT+8

StocksIN